Q1 EPS Forecast for Nektar Therapeutics Boosted by Analyst
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2025 earnings per share estimates for shares of Nektar Therapeutics in a research note issued to investors on Thursday, March 13th. HC Wainwright analyst A. He now expects that the biopharmaceutical company will post earnings of ($0.15) per share for […]
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2025 earnings per share estimates for shares of Nektar Therapeutics in a research note issued to investors on Thursday, March 13th. HC Wainwright analyst A. He now expects that the biopharmaceutical company will post earnings of ($0.15) per share for […]
